Molecular Partners AG (MOLN) CHF0.1

Sell:3.21 CHFBuy:3.48 CHFPrice decreased0.15 CHF (4.46%)

Prices delayed by at least 15 minutes
Sell:3.21 CHF
Buy:3.48 CHF
Change:Price decreased0.15 CHF (4.46%)
Deal now
Prices delayed by at least 15 minutes
Sell:3.21 CHF
Buy:3.48 CHF
Change:Price decreased0.15 CHF (4.46%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Molecular Partners AG is a Switzerland-based company engaged in the pharmaceuticals industry. As a biopharmaceutical company, it is active in the research and development of proteins like DARPins (Designed Ankyrin Repeat Proteins), a new class of small proteins used for the development of medicine against diseases like cancer and sight-threating diseases, among others. The Company’s pipeline is structured mainly through three areas: Ophthalmology, including the creation of therapies for renital diseases like wet age-related macular degeration (wet AMD) and diabetic macular edema (DME); Oncology, containing the development of DARPins against cancer, among others; and Immunology and other Indications, entailing DARPins against several targets important for the treatment of inflammatory and auto-immune diseases.

Key people

William M. Burns
Non-Executive Independent Chairman of the Board
Dominik Hoechli
Non-Executive Independent Director
Sandip S. Kapadia
Non-Executive Independent Director
Patrick Amstutz
Chief Executive Officer, Executive Director, Member of the Management Board
Alexander Zuercher
Chief Operating Officer, Member of the Management Board
Renate Gloggner
Executive Vice President - People and Community, Member of the Management Board
Michael Tobias Stumpp
Executive Vice President - Projects, Member of the Management Board
Martin Steegmaier
Chief Scientific Officer, Member of the Management Board
Philippe Legenne
Chief Medical Officer, Member of the Management Board
Clare Fisher
Director
Agnete B. Fredriksen
Non-Executive Independent Director
Click to see more

Key facts

  • Shares in issue
    40.37m
  • EPIC
    MOLN
  • ISIN
    CH0256379097
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    CHF 129.60m
  • Employees
    149
  • Exchange
    SIX Swiss Exchange
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.